Breast Cancer

News in brief: Pancreatic cancer ‘fortress’ targeted; Breast cancer overdiagnosis claims rebutted; Billion dollar oncology group up for sale

Novel approach targets the fibrosis ‘fortress’ protecting pancreatic cancer Researchers at the University of NDSW are re-purposing an arthritis drug to treat pancreatic cancer, using sulfasalazine to target the dense scar tissue ‘fortress’ that makes the tumour resistant to chemotherapy. A team led by Associate Professor Phoebe Phillips have been working for a decade on ...

Already a member?

Login to keep reading.

© 2022 the limbic